Summary LI#- Hybrid Location: Basel, Switzerland As a Therapeutic Area Biomarker Lead (TABL) in the Biomarker Development (BMD) group, you are accountable for defining and delivering biomarker strategies for the Immunology portfolio across multiple drug development programs